According to the current analysis of Reports and Data, the global Cardiac Biomarkers market was valued at USD 7.96 Billion in 2020 and is expected to reach USD 17.55 Billion by year 2028, at a CAGR of 10.4%.
According to the Centre for Disease Control and Prevention (CDC), for around 610,000 people die of heart disease in United States every year, that’s 1 in every 4 deaths and more than half of the deaths due to heart disease were in men. Cardiac biomarkers are protein-based observable materials discharged into blood when the heart’s muscles are wounded which can be used as risk stratification for numerous cardiovascular diseases (CVDs) that includes Acute Myocardial Infarction (AMI), Ischemia, Congestive Heart Failure (CHF), Acute Coronary Syndrome (ACS) and others related with insufficient blood flow to heart.
The high occurrence rates of CVDs worldwide and the growing demand for POC cardiac testing kits are expected to fuel the market growth. Certain manufacturing, limited specificity and pharmacological issues and regulatory hurdles are hindering the growth of the market.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Key Players covered in this report are
Abbott Laboratories, Alere Inc. and Roche Diagnostics Corporation.
Product Type (Revenue, USD Million; 2020–2028)
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia Modified Albumin (IMA)
- Myoglobin
- Troponins (T and I)
- Myocardial muscle Creatine Kinase (CK-MB)
- Others
Location of Testing (Revenue, USD Million; 2020–2028)
- Laboratory Testing
- Point of Care Testing
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Request a sample Report of Cardiac Biomarkers Market @ https://www.reportsanddata.com/sample-enquiry-form/1423
Major Points covered in this report are as below:
• The Cardiac Biomarkers industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.
• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
• The Cardiac Biomarkers Market report provides key statistics on the market status of the Cardiac Biomarkers manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
Read More Reports:
Proton Therapy Market @ https://www.biospace.com/article/proton-therapy-market-growth-2022-2028-increasing-cancer-prevalence-growing-aging-population-rising-healthcare-expenditure-and-increasing-awareness-about-proton-therapy/
Colonoscopy Bowel Preparation Drugs Market @ https://www.biospace.com/article/colonoscopy-bowel-preparation-drugs-market-growth-2022-2028-increasing-adoption-of-expansion-strategies-such-as-acquisitions-partnerships-and-product-launches/
3D Imaging Market @ https://www.biospace.com/article/three-dimensional-3d-imaging-market-growth-2022-2030-increasing-application-of-virtual-reality-vr-devices-in-the-healthcare-industry/
Artificial Joints Market @ https://www.biospace.com/article/artificial-joints-market-growth-2022-2028-growing-incidences-of-age-related-musculoskeletal-disorders-globally/
Naloxone Hydrochloride Market @ https://www.biospace.com/article/naloxone-hydrochloride-market-growth-by-2027-increasing-prevalence-of-opioid-overdose-and-the-growing-number-of-victims-with-dependency-on-opioid/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
0 Comments
Post a Comment